The University of Chicago Header Logo

Connection

Christopher Salerno to Humans

Back to Details
This is a "connection" page, showing publications Christopher Salerno has written about Humans.
Christopher Salerno
Connection Strength
0.640
Humans
  1. Contemporary Outcomes in the Use of Durable LVADs: An Update From The Society of Thoracic Surgeons Intermacs Database. Ann Thorac Surg. 2024 Jan; 117(1):248-249.
    View in: PubMed
    Score: 0.031
  2. Elective HeartWare HVAD to HeartMate 3 Pump Exchange: Risk Mitigation or Increasing Risk? Ann Thorac Surg. 2023 08; 116(2):438-440.
    View in: PubMed
    Score: 0.030
  3. Commentary: Blood type O, a bigger problem in the new heart allocation system? J Thorac Cardiovasc Surg. 2024 01; 167(1):241-242.
    View in: PubMed
    Score: 0.029
  4. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
    View in: PubMed
    Score: 0.029
  5. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. J Thorac Cardiovasc Surg. 2022 06; 163(6):2120-2127.e5.
    View in: PubMed
    Score: 0.028
  6. HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations. Ann Thorac Surg. 2022 06; 113(6):1770-1777.
    View in: PubMed
    Score: 0.028
  7. Clinical distancing of hospitalized patients with advanced heart failure and cardiac transplantation during COVID-19. J Heart Lung Transplant. 2020 07; 39(7):730.
    View in: PubMed
    Score: 0.025
  8. Opening the "Dor," Not Always an Inferior Approach. ASAIO J. 2019 07; 65(5):e50-e51.
    View in: PubMed
    Score: 0.023
  9. Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. ASAIO J. 2018 Jul/Aug; 64(4):570-572.
    View in: PubMed
    Score: 0.022
  10. Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation: An INTERMACS Analysis. JACC Heart Fail. 2017 10; 5(10):691-699.
    View in: PubMed
    Score: 0.020
  11. INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. J Heart Lung Transplant. 2016 Apr; 35(4):440-8.
    View in: PubMed
    Score: 0.018
  12. Increase in left ventricular assist device thrombosis. N Engl J Med. 2014 04 10; 370(15):1465.
    View in: PubMed
    Score: 0.016
  13. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
    View in: PubMed
    Score: 0.016
  14. [Comparison of the leukaemia incidence in two cohorts of farmers and traders in the Vercelli province of Italy, 2002-2009]. Ann Ig. 2011 Jan-Feb; 23(1):27-32.
    View in: PubMed
    Score: 0.013
  15. Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation? Eur J Cardiothorac Surg. 2007 Mar; 31(3):457-61.
    View in: PubMed
    Score: 0.010
  16. Open-chest management after heart transplantation. Tex Heart Inst J. 2006; 33(3):306-9.
    View in: PubMed
    Score: 0.009
  17. Timing of surgery in asymptomatic mitral regurgitation. N Engl J Med. 2005 Mar 03; 352(9):928-9.
    View in: PubMed
    Score: 0.009
  18. Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail. 2024 Mar; 12(3):438-447.
    View in: PubMed
    Score: 0.008
  19. Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
    View in: PubMed
    Score: 0.008
  20. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device. J Am Coll Cardiol. 2023 08 29; 82(9):771-781.
    View in: PubMed
    Score: 0.008
  21. Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years. Heart Fail Clin. 2024 Jan; 20(1):83-89.
    View in: PubMed
    Score: 0.008
  22. Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 07 04; 82(1):70-81.
    View in: PubMed
    Score: 0.008
  23. Transplantation Outcomes with Donor Hearts after Circulatory Death. N Engl J Med. 2023 Jun 08; 388(23):2121-2131.
    View in: PubMed
    Score: 0.008
  24. Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
    View in: PubMed
    Score: 0.008
  25. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.007
  26. Decreasing blood wastage during ex vivo lung perfusion recovery through utilization of thermal control technology. J Card Surg. 2022 Dec; 37(12):5011-5018.
    View in: PubMed
    Score: 0.007
  27. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 09 27; 328(12):1233-1242.
    View in: PubMed
    Score: 0.007
  28. Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
    View in: PubMed
    Score: 0.007
  29. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. J Thorac Cardiovasc Surg. 2023 12; 166(6):1684-1694.e18.
    View in: PubMed
    Score: 0.007
  30. Comparing short-term/long-term outcomes of heart transplants that occur inside and outside of normal working hours. ESC Heart Fail. 2022 08; 9(4):2484-2490.
    View in: PubMed
    Score: 0.007
  31. Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2022 10; 164(4):1120-1137.e2.
    View in: PubMed
    Score: 0.007
  32. Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2022 12; 114(6):2262-2269.
    View in: PubMed
    Score: 0.007
  33. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021 08; 23(8):1392-1400.
    View in: PubMed
    Score: 0.007
  34. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J Thorac Cardiovasc Surg. 2022 06; 163(6):2107-2116.e6.
    View in: PubMed
    Score: 0.007
  35. The use of enoxaparin as bridge to therapeutic INR after LVAD implantation. J Cardiothorac Surg. 2020 Nov 14; 15(1):329.
    View in: PubMed
    Score: 0.006
  36. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
    View in: PubMed
    Score: 0.006
  37. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications. Ann Thorac Surg. 2020 03; 109(3):649-660.
    View in: PubMed
    Score: 0.006
  38. Hepatitis C donor viremic cardiac transplantation: A practical approach. Clin Transplant. 2020 01; 34(1):e13764.
    View in: PubMed
    Score: 0.006
  39. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg. 1999 Jun; 117(6):1063-9.
    View in: PubMed
    Score: 0.006
  40. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
    View in: PubMed
    Score: 0.006
  41. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 01 08; 139(2):155-168.
    View in: PubMed
    Score: 0.006
  42. Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network. ASAIO J. 2018 Nov/Dec; 64(6):715-720.
    View in: PubMed
    Score: 0.006
  43. Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J. 2018 Nov/Dec; 64(6):721-726.
    View in: PubMed
    Score: 0.006
  44. Bleeding Complication Rates Are Higher in Females after Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):748-753.
    View in: PubMed
    Score: 0.006
  45. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
    View in: PubMed
    Score: 0.006
  46. Primary esophageal lymphoma: a diagnostic challenge. Ann Thorac Surg. 1998 Oct; 66(4):1418-20.
    View in: PubMed
    Score: 0.006
  47. A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 11; 37(11):1281-1284.
    View in: PubMed
    Score: 0.005
  48. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 1998 May; 65(5):1415-9.
    View in: PubMed
    Score: 0.005
  49. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
    View in: PubMed
    Score: 0.005
  50. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 01; 37(1):7-14.
    View in: PubMed
    Score: 0.005
  51. Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
    View in: PubMed
    Score: 0.005
  52. Left Ventricular Assist Devices for Advanced Heart Failure. N Engl J Med. 2017 05 11; 376(19):1894-5.
    View in: PubMed
    Score: 0.005
  53. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
    View in: PubMed
    Score: 0.005
  54. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
    View in: PubMed
    Score: 0.005
  55. Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016 Dec; 22(12):981-987.
    View in: PubMed
    Score: 0.005
  56. Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device. Ann Thorac Surg. 2017 Jan; 103(1):106-112.
    View in: PubMed
    Score: 0.005
  57. The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2016 May-Jun; 62(3):281-5.
    View in: PubMed
    Score: 0.005
  58. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. JACC Heart Fail. 2015 Oct; 3(10):818-28.
    View in: PubMed
    Score: 0.004
  59. Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device. J Card Surg. 2015 Oct; 30(10):775-80.
    View in: PubMed
    Score: 0.004
  60. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):581-9; discussion 589.
    View in: PubMed
    Score: 0.004
  61. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant. 2013 Jul; 32(7):667-70.
    View in: PubMed
    Score: 0.004
  62. Characteristics of extracoronary vascular disease in heart transplant recipient. J Card Surg. 2008 Sep-Oct; 23(5):459-63.
    View in: PubMed
    Score: 0.003
  63. Successful management of asystole with an isolated left ventricular assist device. J Heart Lung Transplant. 2006 Apr; 25(4):490-2.
    View in: PubMed
    Score: 0.002
  64. The effect of changing presentation and management on the outcome of blunt rupture of the thoracic aorta. J Thorac Cardiovasc Surg. 2006 Mar; 131(3):594-600.
    View in: PubMed
    Score: 0.002
  65. Cardiac allograft aortic dissection: successful repair using a composite valve graft and modified-Cabrol coronary reconstruction. J Card Surg. 2005 Sep-Oct; 20(5):450-2.
    View in: PubMed
    Score: 0.002
  66. Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation. J Thorac Cardiovasc Surg. 2000 Apr; 119(4 Pt 1):690-9.
    View in: PubMed
    Score: 0.002
  67. Pulmonary thromboembolectomy of donor lungs prior to lung transplantation. Ann Thorac Surg. 1999 Jun; 67(6):1787-9.
    View in: PubMed
    Score: 0.001
  68. Management of recurrent ventricular tachycardia with ventricular assist device placement. Ann Thorac Surg. 1998 Aug; 66(2):571-3.
    View in: PubMed
    Score: 0.001
  69. Human lung carcinomas express Fas ligand. Cancer Res. 1997 Mar 15; 57(6):1007-12.
    View in: PubMed
    Score: 0.001
  70. Risk of left ventricular assist device as a bridge to heart transplant following postinfarction ventricular septal rupture. J Card Surg. 1997 Mar-Apr; 12(2):93-7.
    View in: PubMed
    Score: 0.001
  71. Coronary sinus injury during retrograde cardioplegia: a report of three cases. J Card Surg. 1996 Sep-Oct; 11(5):359-62.
    View in: PubMed
    Score: 0.001
  72. Pulmonary resection for metastatic breast cancer. Arch Surg. 1992 Nov; 127(11):1282-4.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.